COVID test developers get variant-related FDA guidance

COVID test developers get variant-related FDA guidance

Source: 
RAPS.org
snippet: 

A new guidance from the US Food and Drug Administration (FDA) provides considerations for developers of molecular, antigen and serology COVID-19 tests as they evaluate how viral mutations may affect test performance.